Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis
IFN-γ-producing Th1 and IL-17-producing Th17 cells are the key participants in various autoimmune diseases, including multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). Although both of these T cell subsets are known to be regulated by specific transcription fa...
Uložené v:
| Vydané v: | The Journal of immunology (1950) Ročník 187; číslo 5; s. 2213 |
|---|---|
| Hlavní autori: | , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
01.09.2011
|
| Predmet: | |
| ISSN: | 1550-6606, 1550-6606 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | IFN-γ-producing Th1 and IL-17-producing Th17 cells are the key participants in various autoimmune diseases, including multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). Although both of these T cell subsets are known to be regulated by specific transcription factors and cytokines, the role of microRNAs that control these two inflammatory T cell subsets and whether targeting microRNAs can have therapeutic effects are not known. In this study, we show that microRNA-155 (Mir-155) expression is elevated in CD4(+) T cells during EAE, and Mir-155(-/-) mice had a delayed course and reduced severity of disease and less inflammation in the CNS. The attenuation of EAE in Mir-155(-/-) mice was associated with a decrease in Th1 and Th17 responses in the CNS and peripheral lymphoid organs. The T cell-intrinsic function of Mir-155(-/-) was demonstrated by the resistance of Mir-155(-/-) CD4(+) T cell-repleted Rag-1(-/-) mice to EAE. Finally, we found that anti-Mir-155 treatment reduced clinical severity of EAE when given before and after the appearance of clinical symptoms. These findings demonstrate that Mir-155 confers susceptibility to EAE by affecting inflammatory T cell responses and identify Mir-155 as a new target for therapeutic intervention in multiple sclerosis. |
|---|---|
| AbstractList | IFN-γ-producing Th1 and IL-17-producing Th17 cells are the key participants in various autoimmune diseases, including multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). Although both of these T cell subsets are known to be regulated by specific transcription factors and cytokines, the role of microRNAs that control these two inflammatory T cell subsets and whether targeting microRNAs can have therapeutic effects are not known. In this study, we show that microRNA-155 (Mir-155) expression is elevated in CD4(+) T cells during EAE, and Mir-155(-/-) mice had a delayed course and reduced severity of disease and less inflammation in the CNS. The attenuation of EAE in Mir-155(-/-) mice was associated with a decrease in Th1 and Th17 responses in the CNS and peripheral lymphoid organs. The T cell-intrinsic function of Mir-155(-/-) was demonstrated by the resistance of Mir-155(-/-) CD4(+) T cell-repleted Rag-1(-/-) mice to EAE. Finally, we found that anti-Mir-155 treatment reduced clinical severity of EAE when given before and after the appearance of clinical symptoms. These findings demonstrate that Mir-155 confers susceptibility to EAE by affecting inflammatory T cell responses and identify Mir-155 as a new target for therapeutic intervention in multiple sclerosis. IFN-γ-producing Th1 and IL-17-producing Th17 cells are the key participants in various autoimmune diseases, including multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). Although both of these T cell subsets are known to be regulated by specific transcription factors and cytokines, the role of microRNAs that control these two inflammatory T cell subsets and whether targeting microRNAs can have therapeutic effects are not known. In this study, we show that microRNA-155 (Mir-155) expression is elevated in CD4(+) T cells during EAE, and Mir-155(-/-) mice had a delayed course and reduced severity of disease and less inflammation in the CNS. The attenuation of EAE in Mir-155(-/-) mice was associated with a decrease in Th1 and Th17 responses in the CNS and peripheral lymphoid organs. The T cell-intrinsic function of Mir-155(-/-) was demonstrated by the resistance of Mir-155(-/-) CD4(+) T cell-repleted Rag-1(-/-) mice to EAE. Finally, we found that anti-Mir-155 treatment reduced clinical severity of EAE when given before and after the appearance of clinical symptoms. These findings demonstrate that Mir-155 confers susceptibility to EAE by affecting inflammatory T cell responses and identify Mir-155 as a new target for therapeutic intervention in multiple sclerosis.IFN-γ-producing Th1 and IL-17-producing Th17 cells are the key participants in various autoimmune diseases, including multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). Although both of these T cell subsets are known to be regulated by specific transcription factors and cytokines, the role of microRNAs that control these two inflammatory T cell subsets and whether targeting microRNAs can have therapeutic effects are not known. In this study, we show that microRNA-155 (Mir-155) expression is elevated in CD4(+) T cells during EAE, and Mir-155(-/-) mice had a delayed course and reduced severity of disease and less inflammation in the CNS. The attenuation of EAE in Mir-155(-/-) mice was associated with a decrease in Th1 and Th17 responses in the CNS and peripheral lymphoid organs. The T cell-intrinsic function of Mir-155(-/-) was demonstrated by the resistance of Mir-155(-/-) CD4(+) T cell-repleted Rag-1(-/-) mice to EAE. Finally, we found that anti-Mir-155 treatment reduced clinical severity of EAE when given before and after the appearance of clinical symptoms. These findings demonstrate that Mir-155 confers susceptibility to EAE by affecting inflammatory T cell responses and identify Mir-155 as a new target for therapeutic intervention in multiple sclerosis. |
| Author | Mittal, Akanksha Joller, Nicole Weiner, Howard L Murugaiyan, Gopal Beynon, Vanessa |
| Author_xml | – sequence: 1 givenname: Gopal surname: Murugaiyan fullname: Murugaiyan, Gopal organization: Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA – sequence: 2 givenname: Vanessa surname: Beynon fullname: Beynon, Vanessa – sequence: 3 givenname: Akanksha surname: Mittal fullname: Mittal, Akanksha – sequence: 4 givenname: Nicole surname: Joller fullname: Joller, Nicole – sequence: 5 givenname: Howard L surname: Weiner fullname: Weiner, Howard L |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21788439$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkEtLw0AUhQep2IfuXUl2rlJv5plZlmJVKAo-1mGS3uiUmUzMJGD_vUEruLpn8Z1zOWdOJk1okJDLDJYcuL7ZW--HJrhlBsC0oCdklgkBqZQgJ__0lMxj3AOABMrPyJRmKs850zOyfbEOm8o274m3VReeH1fpaEuMR2dDZ3qMCX612FmPTW9cYoY-_HzFZPRh-2Fc8IcR7m08J6e1cREvjndB3ja3r-v7dPt097BebdOKa9anhuaqZKiVqCUXoEwJdUbzTHFmjKoNSF0hl1qUCnYCBErJSlVmu9xQxgHpglz_5rZd-Bww9oW3sULnTINhiMXYLeeKajWSV0dyKD3uinbsYbpD8TcA_QZRl2B0 |
| CitedBy_id | crossref_primary_10_1016_j_bcp_2020_113822 crossref_primary_10_1517_14728222_2013_838219 crossref_primary_10_1111_acel_14491 crossref_primary_10_1136_annrheumdis_2017_211417 crossref_primary_10_1007_s11892_020_01325_9 crossref_primary_10_1007_s12031_017_0981_2 crossref_primary_10_1016_j_jneuroim_2016_04_014 crossref_primary_10_1186_s12979_022_00281_0 crossref_primary_10_1038_nrneurol_2012_226 crossref_primary_10_1016_j_bbrc_2017_08_075 crossref_primary_10_1007_s12035_013_8400_3 crossref_primary_10_1371_journal_pone_0128198 crossref_primary_10_1111_imr_12060 crossref_primary_10_1186_s13148_016_0253_y crossref_primary_10_1016_j_livres_2017_03_003 crossref_primary_10_1016_j_immuni_2014_03_014 crossref_primary_10_3389_fnmol_2022_865529 crossref_primary_10_1111_imr_13029 crossref_primary_10_3390_ijms19123990 crossref_primary_10_1111_imr_12057 crossref_primary_10_1186_s12974_017_0832_7 crossref_primary_10_1002_ana_24304 crossref_primary_10_3892_ijmm_2016_2610 crossref_primary_10_1002_glia_24622 crossref_primary_10_1007_s11481_013_9498_9 crossref_primary_10_1007_s11892_016_0819_2 crossref_primary_10_1007_s12020_017_1465_4 crossref_primary_10_1172_JCI62636 crossref_primary_10_1186_s12974_016_0753_x crossref_primary_10_1016_j_bbi_2015_07_003 crossref_primary_10_1371_journal_pntd_0001729 crossref_primary_10_1038_s41584_023_00980_y crossref_primary_10_1038_nri3494 crossref_primary_10_1016_j_neulet_2011_11_062 crossref_primary_10_1038_nrd_2015_14 crossref_primary_10_3390_ijms12128695 crossref_primary_10_1111_imr_12049 crossref_primary_10_1111_imm_70033 crossref_primary_10_1038_s41423_022_00933_7 crossref_primary_10_3389_fmolb_2015_00059 crossref_primary_10_3390_ijms17081282 crossref_primary_10_4049_jimmunol_1200728 crossref_primary_10_1007_s00018_014_1670_8 crossref_primary_10_1016_j_gene_2012_12_009 crossref_primary_10_1172_JCI78090 crossref_primary_10_1016_j_canlet_2018_05_019 crossref_primary_10_3389_fgene_2021_717922 crossref_primary_10_1007_s00018_016_2167_4 crossref_primary_10_1111_tri_12528 crossref_primary_10_1134_S0362119720010144 crossref_primary_10_1111_imm_12934 crossref_primary_10_1016_j_ab_2012_09_007 crossref_primary_10_1074_jbc_M115_641837 crossref_primary_10_3389_fimmu_2017_01520 crossref_primary_10_3892_br_2020_1286 crossref_primary_10_4049_jimmunol_1302326 crossref_primary_10_1159_000496344 crossref_primary_10_3390_ijms252111355 crossref_primary_10_3390_ijms21020646 crossref_primary_10_1155_2016_4578230 crossref_primary_10_1161_ATVBAHA_112_300068 crossref_primary_10_1371_journal_pone_0270416 crossref_primary_10_1172_JCI94012 crossref_primary_10_1186_ar4131 crossref_primary_10_3389_fimmu_2018_00057 crossref_primary_10_1161_CIRCRESAHA_112_275214 crossref_primary_10_1038_nri3707 crossref_primary_10_3390_cancers13225651 crossref_primary_10_1016_j_jneuroim_2017_01_016 crossref_primary_10_1182_bloodadvances_2023010570 crossref_primary_10_3389_fnmol_2015_00005 crossref_primary_10_1177_1352458514520911 crossref_primary_10_1177_1756283X14547360 crossref_primary_10_1002_eji_201343962 crossref_primary_10_1155_2021_8825588 crossref_primary_10_1016_j_cca_2025_120506 crossref_primary_10_1038_bmt_2014_277 crossref_primary_10_1177_1073858417721150 crossref_primary_10_1002_ame2_70076 crossref_primary_10_1016_S1474_4422_12_70309_5 crossref_primary_10_1681_ASN_2013020130 crossref_primary_10_1016_j_intimp_2020_106279 crossref_primary_10_1016_j_lfs_2024_122668 crossref_primary_10_1016_j_cellimm_2013_04_001 crossref_primary_10_1186_s12950_017_0162_7 crossref_primary_10_1016_j_ymthe_2017_11_013 crossref_primary_10_1111_imm_12227 crossref_primary_10_3389_fimmu_2018_00992 crossref_primary_10_1172_JCI155693 crossref_primary_10_1186_s12864_020_06794_6 crossref_primary_10_1111_imm_12468 crossref_primary_10_1016_j_jneuroim_2023_578100 crossref_primary_10_1093_intimm_dxu043 crossref_primary_10_1007_s12035_025_04876_8 crossref_primary_10_3389_fncel_2017_00088 crossref_primary_10_1002_glia_23846 crossref_primary_10_3390_ncrna6010010 crossref_primary_10_4049_jimmunol_1202700 crossref_primary_10_1261_rna_035394_112 crossref_primary_10_1038_srep22613 crossref_primary_10_1016_j_jaut_2019_04_002 crossref_primary_10_1016_j_bbagrm_2020_194639 crossref_primary_10_1177_1352458519879303 crossref_primary_10_1136_gutjnl_2014_307891 crossref_primary_10_4103_1673_5374_346462 crossref_primary_10_1016_j_jtos_2024_01_004 crossref_primary_10_1371_journal_pone_0079416 crossref_primary_10_3389_fimmu_2017_01932 crossref_primary_10_1111_bjh_14295 crossref_primary_10_1111_jcmm_12003 crossref_primary_10_1007_s00415_016_8293_y crossref_primary_10_3390_ijms22094332 crossref_primary_10_1186_s11658_022_00377_x crossref_primary_10_1128_MCB_06597_11 crossref_primary_10_1007_s12035_016_0245_0 crossref_primary_10_3389_fimmu_2015_00549 crossref_primary_10_1002_ana_23967 crossref_primary_10_1016_j_bcp_2016_07_002 crossref_primary_10_1126_scitranslmed_adp5802 crossref_primary_10_3390_ijms131013227 crossref_primary_10_3389_fimmu_2022_865777 crossref_primary_10_1111_cen3_12131 crossref_primary_10_1111_imr_12208 crossref_primary_10_1371_journal_pone_0070945 crossref_primary_10_1002_btpr_3383 crossref_primary_10_1016_j_molmet_2019_06_009 crossref_primary_10_1016_j_pneurobio_2019_101664 crossref_primary_10_1038_icb_2014_105 crossref_primary_10_1186_s12967_018_1565_9 crossref_primary_10_1586_14789450_2015_1099435 crossref_primary_10_1016_j_autrev_2024_103739 crossref_primary_10_1016_j_jns_2020_117202 crossref_primary_10_1002_glia_23819 crossref_primary_10_1016_j_msard_2023_104554 crossref_primary_10_1073_pnas_2011574118 crossref_primary_10_1002_acn3_55 crossref_primary_10_1111_ijlh_14243 crossref_primary_10_1523_JNEUROSCI_2830_15_2015 crossref_primary_10_1371_journal_pone_0144810 crossref_primary_10_1007_s10571_025_01578_6 crossref_primary_10_1155_2014_295651 crossref_primary_10_3389_fendo_2020_606322 crossref_primary_10_1016_j_ajpath_2014_12_021 crossref_primary_10_1128_IAI_01666_14 crossref_primary_10_1007_s11033_022_08033_5 crossref_primary_10_1371_journal_pone_0145237 crossref_primary_10_1161_CIRCRESAHA_112_267443 crossref_primary_10_3390_ijms21082823 crossref_primary_10_1093_jleuko_qiae059 crossref_primary_10_1160_TH11_08_0603 crossref_primary_10_1172_JCI74347 crossref_primary_10_1016_j_molmed_2025_03_006 crossref_primary_10_1002_ana_23880 crossref_primary_10_1016_j_semcancer_2015_03_006 crossref_primary_10_1111_sji_12276 crossref_primary_10_3389_fimmu_2021_669382 crossref_primary_10_1007_s10565_024_09920_2 crossref_primary_10_1007_s13311_018_0665_9 crossref_primary_10_1016_j_jneuroim_2012_02_012 crossref_primary_10_1007_s11064_014_1386_z crossref_primary_10_1093_jambio_lxad104 crossref_primary_10_1016_j_cellimm_2020_104219 crossref_primary_10_1016_j_immuni_2012_12_006 crossref_primary_10_4049_jimmunol_1303488 crossref_primary_10_1080_1744666X_2017_1297232 crossref_primary_10_1186_s12974_020_01929_8 crossref_primary_10_4049_jimmunol_1700170 crossref_primary_10_4049_jimmunol_1403028 crossref_primary_10_4049_jimmunol_1403146 crossref_primary_10_4049_jimmunol_2200478 crossref_primary_10_1016_j_coph_2015_09_001 crossref_primary_10_1016_j_intimp_2021_107811 crossref_primary_10_1002_eji_201445066 crossref_primary_10_1007_s11064_019_02777_6 crossref_primary_10_36290_neu_2022_059 crossref_primary_10_1002_eji_201545487 crossref_primary_10_1016_j_biopha_2018_05_050 crossref_primary_10_3389_fimmu_2020_571897 crossref_primary_10_3390_molecules22020225 crossref_primary_10_7554_eLife_56916 crossref_primary_10_1016_j_immuni_2015_04_022 crossref_primary_10_1016_j_phanu_2020_100242 crossref_primary_10_1096_fj_201600435RR crossref_primary_10_1097_MD_0000000000029107 crossref_primary_10_1016_j_mam_2019_09_004 crossref_primary_10_1016_j_msard_2024_105764 crossref_primary_10_1007_s00296_012_2559_1 crossref_primary_10_1074_jbc_M114_577429 crossref_primary_10_1128_IAI_02251_14 crossref_primary_10_3390_ijms23010090 crossref_primary_10_1128_JVI_02979_13 crossref_primary_10_3389_fnmol_2018_00058 crossref_primary_10_1016_j_semcancer_2019_04_004 crossref_primary_10_1186_s12974_016_0699_z crossref_primary_10_1007_s10753_014_9961_7 crossref_primary_10_1016_j_jneuroim_2013_09_019 crossref_primary_10_1007_s12017_014_8335_5 crossref_primary_10_1016_j_imlet_2020_05_003 crossref_primary_10_1038_s41385_019_0241_6 crossref_primary_10_1182_blood_2014_12_617258 crossref_primary_10_1096_fj_13_248880 crossref_primary_10_1111_cea_12135 crossref_primary_10_1007_s00011_022_01643_6 crossref_primary_10_1007_s12017_014_8298_6 crossref_primary_10_1111_imm_12611 crossref_primary_10_3389_fimmu_2023_1257192 crossref_primary_10_3390_cells11091380 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.4049/jimmunol.1003952 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1550-6606 |
| ExternalDocumentID | 21788439 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R01 AI043458 – fundername: NINDS NIH HHS grantid: NS23132 – fundername: NINDS NIH HHS grantid: R01 NS023132 – fundername: NINDS NIH HHS grantid: P01 NS038037 – fundername: NINDS NIH HHS grantid: NS038037 – fundername: NIAID NIH HHS grantid: AI043458 |
| GroupedDBID | --- -~X .55 0R~ 18M 1KJ 2WC 34G 39C 3O- 53G 5GY 5RE 5VS 5WD 79B 85S AARDX ABCQX ABDFA ABEJV ABGNP ABJNI ABOCM ABPPZ ACGFO ACGFS ACIWK ACNCT ACPRK ADBBV ADIPN ADNWM AENEX AETEA AFFNX AFHIN AFOSN AFRAH AGORE AHMMS AHWXS AIZAD ALMA_UNASSIGNED_HOLDINGS ARBBW BAWUL BCRHZ BTFSW CGR CUY CVF D0L DIK DU5 E3Z EBS ECM EIF EJD F5P FRP GX1 H13 IH2 K-O KQ8 L7B NPM OCZFY OK1 OWPYF P0W P2P PQQKQ R.V RHI ROX RZQ SJN TR2 TWZ W8F WH7 WOQ X7M XJT XSW XTH YHG 7X8 ABXVV KOP |
| ID | FETCH-LOGICAL-c493t-a287b3e975f64507ab0f1281743aa7fa069ce4695b70d505e663b7b1d8a2340e2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 257 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000294059500025&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1550-6606 |
| IngestDate | Sat Sep 27 23:35:41 EDT 2025 Sat May 31 02:06:01 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c493t-a287b3e975f64507ab0f1281743aa7fa069ce4695b70d505e663b7b1d8a2340e2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://journals.aai.org/jimmunol/article-pdf/187/5/2213/1348285/1003952.pdf |
| PMID | 21788439 |
| PQID | 884847297 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_884847297 pubmed_primary_21788439 |
| PublicationCentury | 2000 |
| PublicationDate | 2011-09-01 |
| PublicationDateYYYYMMDD | 2011-09-01 |
| PublicationDate_xml | – month: 09 year: 2011 text: 2011-09-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | The Journal of immunology (1950) |
| PublicationTitleAlternate | J Immunol |
| PublicationYear | 2011 |
| SSID | ssj0006024 |
| Score | 2.5063114 |
| Snippet | IFN-γ-producing Th1 and IL-17-producing Th17 cells are the key participants in various autoimmune diseases, including multiple sclerosis and its animal model,... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 2213 |
| SubjectTerms | Animals CD4-Positive T-Lymphocytes - immunology Encephalomyelitis, Autoimmune, Experimental - genetics Encephalomyelitis, Autoimmune, Experimental - immunology Gene Silencing Inflammation - genetics Inflammation - immunology Mice Mice, Inbred C57BL Mice, Knockout MicroRNAs - genetics MicroRNAs - immunology Reverse Transcriptase Polymerase Chain Reaction T-Lymphocyte Subsets - immunology |
| Title | Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/21788439 https://www.proquest.com/docview/884847297 |
| Volume | 187 |
| WOSCitedRecordID | wos000294059500025&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwED4BBcTCo7zKSx5Yraaxm8QTqhAVQxtVPKRuke3YoqhNCm2R-u85JymwIAaWLFGk-OS7-873nT-Aa996hmtpaeTbiHKdKqoM-pWDFhYTAvp6oVrSC-M4Gg7FoOLmzCpa5SomFoE6zbU7I29GEcdA6ovwZvpGnWiUa65WChrrUGOIZByjKxx-XxYeeKWmLYJwGiBQL7uUHDFx83Xkpi_ysSMJMOGmjn7Dl0We6e798w_3YbcCmKRT7ogDWDNZHbZKycllHbb7VTP9EHqPIzdxhLmLTBwt7yHuoPHaRE7M2A3uIwglPwUAiFzM82JFhrh4MH2R43yyNI5ANzuC5-7d0-09rcQVqOaCzanEUkkxI8K2DTiCQqk867pqiCikDK30AqEN1s5tFXopwiSD0ESFqpVG0mfcM_4xbGR5Zk6BiLSVKqFZIAzjSniCRVqlrcD3PYvVX9AAsjJYgpvXdSRkZvLFLPkyWQNOSqMn0_KSjQRLJXzLxNnfH5_DTnnS65hfF1Cz6LjmEjb1By7__arYFPiMB_1PhUzCSw |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Silencing+microRNA-155+ameliorates+experimental+autoimmune+encephalomyelitis&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Murugaiyan%2C+Gopal&rft.au=Beynon%2C+Vanessa&rft.au=Mittal%2C+Akanksha&rft.au=Joller%2C+Nicole&rft.date=2011-09-01&rft.eissn=1550-6606&rft.volume=187&rft.issue=5&rft.spage=2213&rft_id=info:doi/10.4049%2Fjimmunol.1003952&rft_id=info%3Apmid%2F21788439&rft_id=info%3Apmid%2F21788439&rft.externalDocID=21788439 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1550-6606&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1550-6606&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1550-6606&client=summon |